| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.17e-06 | 562 | 32 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA3 NFKBIZ YY1AP1 SSX8P MRTFB ITGA2B SSX1 USP16 EP300 WNK3 RAPGEF4 | 4.64e-06 | 1356 | 32 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA3 NFKBIZ YY1AP1 SSX8P MRTFB SSX1 USP16 EP300 WNK3 RAPGEF4 | 8.38e-06 | 1160 | 32 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA3 NFKBIZ KLF12 HOXC5 ZNF547 STOX1 ZKSCAN4 KLF5 GLI2 EP300 | 6.11e-05 | 1459 | 32 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.13e-04 | 21 | 32 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.08e-04 | 1244 | 32 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.01e-04 | 1271 | 32 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.27e-03 | 33 | 32 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.34e-03 | 303 | 32 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.60e-03 | 37 | 32 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.02e-03 | 51 | 32 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.50e-03 | 55 | 32 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.16e-03 | 60 | 32 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.78e-03 | 229 | 32 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 5.78e-03 | 229 | 32 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 6.12e-03 | 1412 | 32 | 7 | GO:0000981 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.93e-03 | 78 | 32 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 7.81e-03 | 83 | 32 | 2 | GO:1990841 | |
| Domain | DUF4599 | 1.20e-06 | 12 | 34 | 3 | PF15371 | |
| Domain | DUF4599 | 1.20e-06 | 12 | 34 | 3 | IPR027970 | |
| Domain | Nuc_rcpt_coact | 4.80e-05 | 6 | 34 | 2 | IPR009110 | |
| Domain | KRAB_RELATED | 1.75e-04 | 11 | 34 | 2 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 2.48e-04 | 13 | 34 | 2 | IPR003655 | |
| Domain | FA58C | 6.61e-04 | 21 | 34 | 2 | SM00231 | |
| Domain | FA58C_3 | 6.61e-04 | 21 | 34 | 2 | PS50022 | |
| Domain | FA58C_1 | 6.61e-04 | 21 | 34 | 2 | PS01285 | |
| Domain | FA58C_2 | 6.61e-04 | 21 | 34 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 8.66e-04 | 24 | 34 | 2 | PF00754 | |
| Domain | FA58C | 8.66e-04 | 24 | 34 | 2 | IPR000421 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.54e-03 | 32 | 34 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.54e-03 | 32 | 34 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 1.54e-03 | 32 | 34 | 2 | PS00514 | |
| Domain | LAM_G_DOMAIN | 2.17e-03 | 38 | 34 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 2.40e-03 | 40 | 34 | 2 | PF02210 | |
| Domain | LamG | 2.90e-03 | 44 | 34 | 2 | SM00282 | |
| Domain | KRAB | 3.91e-03 | 358 | 34 | 4 | PF01352 | |
| Domain | KRAB | 4.35e-03 | 369 | 34 | 4 | SM00349 | |
| Domain | KRAB | 4.40e-03 | 370 | 34 | 4 | IPR001909 | |
| Domain | Laminin_G | 4.99e-03 | 58 | 34 | 2 | IPR001791 | |
| Domain | - | 7.27e-03 | 679 | 34 | 5 | 3.30.160.60 | |
| Domain | zf-C2H2 | 7.90e-03 | 693 | 34 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 7.95e-03 | 694 | 34 | 5 | IPR013087 | |
| Domain | - | 8.64e-03 | 449 | 34 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 9.32e-03 | 459 | 34 | 4 | IPR013083 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.24e-02 | 775 | 34 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.26e-02 | 777 | 34 | 5 | PS00028 | |
| Domain | Galactose-bd-like | 1.27e-02 | 94 | 34 | 2 | IPR008979 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31150793 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26807827 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 15668237 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 14612398 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 2.78e-06 | 3 | 34 | 2 | 11823864 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 21454665 | ||
| Pubmed | AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. | 2.78e-06 | 3 | 34 | 2 | 10866661 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 15145939 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 37156774 | ||
| Pubmed | The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. | 2.78e-06 | 3 | 34 | 2 | 12569362 | |
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 5.56e-06 | 4 | 34 | 2 | 10655477 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 16227615 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 33589584 | ||
| Pubmed | Significance of the transcription factor KLF5 in cardiovascular remodeling. | 5.56e-06 | 4 | 34 | 2 | 16102021 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 23880760 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 32668201 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 9858544 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 11701890 | ||
| Pubmed | 6.73e-06 | 1429 | 34 | 9 | 35140242 | ||
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 20101243 | ||
| Pubmed | Structure of a biologically active estrogen receptor-coactivator complex on DNA. | 9.26e-06 | 5 | 34 | 2 | 25728767 | |
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 9.26e-06 | 5 | 34 | 2 | 9812974 | |
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 12714702 | ||
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 30418174 | ||
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 17360478 | ||
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 20850414 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 1.39e-05 | 6 | 34 | 2 | 11076796 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.39e-05 | 6 | 34 | 2 | 34143959 | |
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 23134681 | ||
| Pubmed | Structural and Functional Impacts of ER Coactivator Sequential Recruitment. | 1.39e-05 | 6 | 34 | 2 | 28844863 | |
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 1.39e-05 | 6 | 34 | 2 | 20368990 | |
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.39e-05 | 6 | 34 | 2 | 25930072 | |
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 16923966 | ||
| Pubmed | Activation of rapid oestrogen signalling in aggressive human breast cancers. | 1.39e-05 | 6 | 34 | 2 | 23065768 | |
| Pubmed | 1.94e-05 | 7 | 34 | 2 | 12709428 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 12082103 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 19419955 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 17475621 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 14747462 | ||
| Pubmed | 2.59e-05 | 8 | 34 | 2 | 10490106 | ||
| Pubmed | 3.33e-05 | 9 | 34 | 2 | 11087842 | ||
| Pubmed | 3.33e-05 | 9 | 34 | 2 | 14611804 | ||
| Pubmed | 4.15e-05 | 10 | 34 | 2 | 11163245 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.84e-05 | 430 | 34 | 5 | 35044719 | |
| Pubmed | 6.08e-05 | 12 | 34 | 2 | 15937668 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 6.08e-05 | 12 | 34 | 2 | 14645221 | |
| Pubmed | 7.43e-05 | 83 | 34 | 3 | 28794006 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 8.38e-05 | 14 | 34 | 2 | 11500849 | |
| Pubmed | Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. | 8.38e-05 | 14 | 34 | 2 | 26166704 | |
| Pubmed | 9.66e-05 | 15 | 34 | 2 | 9267036 | ||
| Pubmed | 1.19e-04 | 808 | 34 | 6 | 20412781 | ||
| Pubmed | 1.25e-04 | 17 | 34 | 2 | 26389685 | ||
| Pubmed | 1.25e-04 | 17 | 34 | 2 | 19183483 | ||
| Pubmed | 1.33e-04 | 268 | 34 | 4 | 33640491 | ||
| Pubmed | 1.74e-04 | 20 | 34 | 2 | 11877444 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.86e-04 | 877 | 34 | 6 | 20211142 | |
| Pubmed | 1.93e-04 | 21 | 34 | 2 | 19596656 | ||
| Pubmed | 1.93e-04 | 21 | 34 | 2 | 12216073 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 2.12e-04 | 22 | 34 | 2 | 26494785 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.52e-04 | 588 | 34 | 5 | 38580884 | |
| Pubmed | Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. | 2.53e-04 | 24 | 34 | 2 | 21803035 | |
| Pubmed | 2.53e-04 | 24 | 34 | 2 | 32212159 | ||
| Pubmed | 2.53e-04 | 24 | 34 | 2 | 39012257 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 2.74e-04 | 25 | 34 | 2 | 15820306 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.34e-04 | 341 | 34 | 4 | 32971831 | |
| Pubmed | 3.45e-04 | 28 | 34 | 2 | 24880616 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 3.70e-04 | 29 | 34 | 2 | 31491374 | |
| Pubmed | 3.70e-04 | 29 | 34 | 2 | 39289460 | ||
| Pubmed | 4.43e-04 | 152 | 34 | 3 | 38360978 | ||
| Pubmed | 4.81e-04 | 33 | 34 | 2 | 32140074 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 5.83e-04 | 167 | 34 | 3 | 20362541 | |
| Pubmed | 6.05e-04 | 37 | 34 | 2 | 23266329 | ||
| Pubmed | 6.14e-04 | 170 | 34 | 3 | 15057823 | ||
| Pubmed | 6.31e-04 | 1103 | 34 | 6 | 34189442 | ||
| Pubmed | 6.49e-04 | 407 | 34 | 4 | 15772651 | ||
| Pubmed | 7.07e-04 | 40 | 34 | 2 | 28805822 | ||
| Pubmed | 7.17e-04 | 418 | 34 | 4 | 34709266 | ||
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 8.94e-04 | 45 | 34 | 2 | 27337956 | |
| Interaction | EPC1 interactions | 7.99e-06 | 81 | 32 | 4 | int:EPC1 | |
| Cytoband | 9p11.2 | 2.29e-04 | 30 | 34 | 2 | 9p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p11 | 6.90e-04 | 52 | 34 | 2 | chr9p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q22 | 9.79e-04 | 62 | 34 | 2 | chr13q22 | |
| Cytoband | Xp11.23 | 2.28e-03 | 95 | 34 | 2 | Xp11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 2.72e-03 | 377 | 34 | 3 | chrXp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q22 | 9.67e-03 | 200 | 34 | 2 | chr9q22 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.26e-04 | 17 | 18 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.42e-04 | 18 | 18 | 2 | 624 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.42e-04 | 718 | 18 | 5 | 28 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.37e-02 | 181 | 18 | 2 | 694 | |
| Coexpression | HOOI_ST7_TARGETS_DN | 1.15e-05 | 115 | 32 | 4 | M14801 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.78e-06 | 167 | 34 | 4 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.95e-06 | 173 | 34 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 180 | 34 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-05 | 185 | 34 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-05 | 187 | 34 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 189 | 34 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-05 | 191 | 34 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 192 | 34 | 4 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 193 | 34 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 193 | 34 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 193 | 34 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 194 | 34 | 4 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-05 | 196 | 34 | 4 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 196 | 34 | 4 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 198 | 34 | 4 | 8a1f984e46f4fa5be33027b9dbaa2ca060a2245d | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.58e-05 | 200 | 34 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-04 | 155 | 34 | 3 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.39e-04 | 159 | 34 | 3 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.48e-04 | 161 | 34 | 3 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.67e-04 | 165 | 34 | 3 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-04 | 165 | 34 | 3 | 2d01ae5d05fe55f6bebd53a5801c4c1f1544515c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-04 | 167 | 34 | 3 | d26e4cea67177975ba15f393e8521be91e148ac9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 171 | 34 | 3 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 172 | 34 | 3 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.01e-04 | 172 | 34 | 3 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 172 | 34 | 3 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 172 | 34 | 3 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 174 | 34 | 3 | 8a8e98e62c2859c004b44dbce6974c9639ebeac6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.11e-04 | 174 | 34 | 3 | 31f7127faabcb1092bb9827db625f57cf7d8240e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.17e-04 | 175 | 34 | 3 | ba1befc4e5f0167452f9ceace39377d16136dfa9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-04 | 176 | 34 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-04 | 178 | 34 | 3 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-04 | 179 | 34 | 3 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 3.44e-04 | 180 | 34 | 3 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.44e-04 | 180 | 34 | 3 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-04 | 180 | 34 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 181 | 34 | 3 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 3.50e-04 | 181 | 34 | 3 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-04 | 182 | 34 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.55e-04 | 182 | 34 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-04 | 183 | 34 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 183 | 34 | 3 | 1e51aeaa8fc9383b424cce128a890e07cb6025f3 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-04 | 183 | 34 | 3 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.61e-04 | 183 | 34 | 3 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-04 | 183 | 34 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | facs-Lung-Endomucin-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 183 | 34 | 3 | 3dc6cbe803e5b8c4201faaf2e6445898d71684e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.67e-04 | 184 | 34 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 184 | 34 | 3 | af5eb3650fafc808828eb42f68c0f1e9c278adbb | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 3.67e-04 | 184 | 34 | 3 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | f262b441ea3fe7f69dff33d5f171000371f3a3e5 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.73e-04 | 185 | 34 | 3 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.73e-04 | 185 | 34 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.79e-04 | 186 | 34 | 3 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 186 | 34 | 3 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.79e-04 | 186 | 34 | 3 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 186 | 34 | 3 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 186 | 34 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-04 | 187 | 34 | 3 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-04 | 187 | 34 | 3 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-04 | 187 | 34 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 187 | 34 | 3 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 187 | 34 | 3 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.85e-04 | 187 | 34 | 3 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.85e-04 | 187 | 34 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-04 | 188 | 34 | 3 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 188 | 34 | 3 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.91e-04 | 188 | 34 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 188 | 34 | 3 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.97e-04 | 189 | 34 | 3 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.97e-04 | 189 | 34 | 3 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-04 | 189 | 34 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.97e-04 | 189 | 34 | 3 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.97e-04 | 189 | 34 | 3 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 4.03e-04 | 190 | 34 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.03e-04 | 190 | 34 | 3 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.03e-04 | 190 | 34 | 3 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-04 | 190 | 34 | 3 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 190 | 34 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 4.09e-04 | 191 | 34 | 3 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.09e-04 | 191 | 34 | 3 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-04 | 191 | 34 | 3 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 192 | 34 | 3 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.15e-04 | 192 | 34 | 3 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 192 | 34 | 3 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-04 | 192 | 34 | 3 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 192 | 34 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-04 | 193 | 34 | 3 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-04 | 193 | 34 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| Disease | eosinophil cationic protein measurement | 6.46e-08 | 8 | 32 | 3 | EFO_0010913 | |
| Disease | renal overload-type gout | 1.70e-05 | 6 | 32 | 2 | EFO_0021525 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.18e-05 | 8 | 32 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | longitudinal alcohol consumption measurement | 4.08e-05 | 9 | 32 | 2 | EFO_0007645 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 8.82e-05 | 13 | 32 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | amygdala volume change measurement | 1.35e-04 | 16 | 32 | 2 | EFO_0021490 | |
| Disease | Squamous cell carcinoma | 3.29e-04 | 124 | 32 | 3 | C0007137 | |
| Disease | breast carcinoma (is_marker_for) | 2.34e-03 | 66 | 32 | 2 | DOID:3459 (is_marker_for) | |
| Disease | Pancreatic Neoplasm | 5.28e-03 | 100 | 32 | 2 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 5.49e-03 | 102 | 32 | 2 | C0346647 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQTQFPSQGMNVTNI | 766 | Q09472 | |
| MMGNVSFSCPQPQTV | 356 | Q9BZ76 | |
| MNRKNTPYQQGTPCA | 176 | P16562 | |
| NPVNPIQMNSQSSVK | 281 | Q9NTZ6 | |
| KQSPNIPAYNMQTCG | 11 | Q00444 | |
| PQKCQPFQVRGSQQM | 266 | Q9BYH8 | |
| KLQTSPQAGMQTQPQ | 736 | Q9ULH7 | |
| FGAPSSLNKNNMPVQ | 1131 | P10070 | |
| QQAQPDSMLGVPSKC | 791 | Q9NYA4 | |
| QQVFMLDTQCSPKTP | 1666 | Q5TH69 | |
| NRMNNQKFPCSISPF | 281 | Q9Y4X4 | |
| MMGNVSFSCPQPQTV | 356 | Q96NU0 | |
| NSQPQQKYTVMSGTP | 491 | Q8WZA2 | |
| QQTTDNNPPMKLVCG | 341 | Q9H871 | |
| PMKNTGVACPASQNK | 371 | B4DYI2 | |
| NPNCQGSCKSQSPMF | 936 | B4DYI2 | |
| NPNCQGSCKSQRPMF | 1086 | Q5VVP1 | |
| SPNMNITQPSKVSNQ | 551 | Q9Y6Q9 | |
| QTQMPTGQTGNCESP | 366 | Q9P2F8 | |
| LPQTKTPVSCFNIQM | 506 | P08514 | |
| RNPNCQGSCKSQSPM | 941 | P0DKV0 | |
| VCGNPNMTCPSNKTR | 81 | P10153 | |
| TLPPFMCNKQATDFQ | 66 | Q16384 | |
| TGQTVCKNKPNMSDP | 591 | Q15021 | |
| PMNSPCQITVKGLSN | 186 | Q9Y5T5 | |
| PQQSMLQNDGKCCPF | 586 | Q6ZVD7 | |
| TLPPFMCNKQATDFQ | 66 | Q7RTT4 | |
| EFQKAFNCPPNSTMN | 726 | P78562 | |
| GNHVQPPETMKCNTF | 186 | Q9UIL8 | |
| NPKFQTLFQPCNLMG | 221 | Q9H869 | |
| CQQNEPNMTTQKGPE | 801 | Q9UBW7 | |
| QTQGSQSSQCQPMKA | 161 | Q969J2 | |
| VSQVMAPKPCLSTQN | 71 | Q8IVP9 | |
| SFSCSPQPSQQMKVL | 16 | Q9UI25 | |
| PQPSQQMKVLFVGNS | 21 | Q9UI25 | |
| CKSMGNVFPQPQNTT | 511 | Q9BYP7 | |
| PQTAVKQFQGMPPCT | 271 | Q13887 |